Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Critical view of anaphylaxis epidemiology: open questions and new perspectives.

Tanno LK, Bierrenbach AL, Simons FER, Cardona V, Thong BY, Molinari N, Calderon MA, Worm M, Chang YS, Papadopoulos NG, Casale T, Demoly P; on behalf the Joint Allergy Academies.

Allergy Asthma Clin Immunol. 2018 Apr 4;14:12. doi: 10.1186/s13223-018-0234-0. eCollection 2018. Review.

2.

New trends in anaphylaxis.

Worm M, Sturm G, Kleine-Tebbe J, Cichocka-Jarosz E, Cardona V, Maris I, Dölle S.

Allergo J Int. 2017;26(8):295-300. doi: 10.1007/s40629-017-0042-y. Epub 2017 Nov 15. Review.

3.

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

Dhami S, Nurmatov U, Roberts G, Pfaar O, Muraro A, Ansotegui IJ, Calderon M, Cingi C, Demoly P, Durham S, van Wijk RG, Halken S, Hamelmann E, Hellings P, Jacobsen L, Knol E, Linnemann DL, Lin S, Maggina V, Oude-Elberink H, Pajno G, Panwankar R, Pastorello E, Pitsios C, Rotiroti G, Timmermans F, Tsilochristou O, Varga EM, Wilkinson J, Williams A, Worm M, Zhang L, Sheikh A.

Clin Transl Allergy. 2017 Sep 15;7:29. doi: 10.1186/s13601-017-0168-5. eCollection 2017.

4.

Social interactions between live and artificial weakly electric fish: Electrocommunication and locomotor behavior of Mormyrus rume proboscirostris towards a mobile dummy fish.

Worm M, Kirschbaum F, von der Emde G.

PLoS One. 2017 Sep 13;12(9):e0184622. doi: 10.1371/journal.pone.0184622. eCollection 2017.

5.

Apoptotic resistance of human skin mast cells is mediated by Mcl-1.

Hazzan T, Eberle J, Worm M, Babina M.

Cell Death Discov. 2017 Aug 21;3:17048. doi: 10.1038/cddiscovery.2017.48. eCollection 2017.

6.

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews.

Nurmatov U, Dhami S, Arasi S, Roberts G, Pfaar O, Muraro A, Ansotegui IJ, Calderon M, Cingi C, Durham S, van Wijk RG, Halken S, Hamelmann E, Hellings P, Jacobsen L, Knol E, Larenas-Linnemann D, Lin SY, Maggina V, Oude-Elberink H, Pajno G, Panwankar R, Pastorello E, Pitsios C, Rotiroti G, Timmermans F, Tsilochristou O, Varga EM, Wilkinson J, Williams A, Worm M, Zhang L, Sheikh A.

Clin Transl Allergy. 2017 Aug 8;7:24. doi: 10.1186/s13601-017-0159-6. eCollection 2017. Review.

7.

Quality indicators for the acute and long-term management of anaphylaxis: a systematic review.

Dhami S, Sheikh A, Muraro A, Roberts G, Halken S, Fernandez Rivas M, Worm M, Sheikh A.

Clin Transl Allergy. 2017 May 24;7:15. doi: 10.1186/s13601-017-0151-1. eCollection 2017. Review.

8.

In-flight allergic emergencies.

Sánchez-Borges M, Cardona V, Worm M, Lockey RF, Sheikh A, Greenberger PA, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fineman S, Geller M, Gonzalez-Estrada A, Tanno L, Thong BY; WAO Anaphylaxis Committee.

World Allergy Organ J. 2017 May 4;10(1):15. doi: 10.1186/s40413-017-0148-1. eCollection 2017. Review.

9.
10.

Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol.

Wylon K, Drozdenko G, Krannich A, Heine G, Dölle S, Worm M.

PLoS One. 2017 Jan 23;12(1):e0169620. doi: 10.1371/journal.pone.0169620. eCollection 2017.

11.

Exploratory analysis of CD63 and CD203c expression in basophils from hazelnut sensitized and allergic individuals.

Lötzsch B, Dölle S, Vieths S, Worm M.

Clin Transl Allergy. 2016 Dec 13;6:45. doi: 10.1186/s13601-016-0134-7. eCollection 2016.

12.

Polyethylene glycol as a cause of anaphylaxis.

Wylon K, Dölle S, Worm M.

Allergy Asthma Clin Immunol. 2016 Dec 13;12:67. doi: 10.1186/s13223-016-0172-7. eCollection 2016.

13.

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Calderon MA, Demoly P, Casale T, Akdis CA, Bachert C, Bewick M, Bilò BM, Bohle B, Bonini S, Bush A, Caimmi DP, Canonica GW, Cardona V, Chiriac AM, Cox L, Custovic A, De Blay F, Devillier P, Didier A, Di Lorenzo G, Du Toit G, Durham SR, Eng P, Fiocchi A, Fox AT, van Wijk RG, Gomez RM, Haathela T, Halken S, Hellings PW, Jacobsen L, Just J, Tanno LK, Kleine-Tebbe J, Klimek L, Knol EF, Kuna P, Larenas-Linnemann DE, Linneberg A, Matricardi M, Malling HJ, Moesges R, Mullol J, Muraro A, Papadopoulos N, Passalacqua G, Pastorello E, Pfaar O, Price D, Del Rio PR, Ruëff R, Samolinski B, Scadding GK, Senti G, Shamji MH, Sheikh A, Sisul JC, Sole D, Sturm GJ, Tabar A, Van Ree R, Ventura MT, Vidal C, Varga EM, Worm M, Zuberbier T, Bousquet J.

Clin Transl Allergy. 2016 Nov 23;6:41. eCollection 2016. Review.

14.

Standardization of double blind placebo controlled food challenge with soy within a multicentre trial.

Treudler R, Franke A, Schmiedeknecht A, Ballmer-Weber BK, Worm M, Werfel T, Jappe U, Biedermann T, Schmitt J, Brehler R, Kleinheinz A, Kleine-Tebbe J, Brüning H, Ruëff F, Ring J, Saloga J, Schäkel K, Holzhauser T, Vieths S, Simon JC.

Clin Transl Allergy. 2016 Nov 7;6:39. eCollection 2016.

15.

Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting.

Hahn-Pedersen J, Worm M, Green W, Andreasen JN, Taylor M.

Clin Transl Allergy. 2016 Sep 7;6(1):35. doi: 10.1186/s13601-016-0127-6. eCollection 2016.

16.

S2k guideline on diagnosis and treatment of atopic dermatitis - short version.

Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, Fölster-Holst R, Gieler U, Kahle J, Kapp A, Nast A, Nemat K, Ott H, Przybilla B, Roecken M, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Staab D, Worm M.

Allergo J Int. 2016;25:82-95. Epub 2016 May 2. Review.

17.

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

Dhami S, Nurmatov U, Roberts G, Pfaar O, Muraro A, Ansotegui IJ, Calderon M, Cingi C, Demoly P, Durham S, van Wijk RG, Halken S, Hamelmann E, Hellings P, Jacobsen L, Knol E, Larenas-Linnemann D, Lin S, Maggina V, Oude-Elberink H, Pajno G, Panwankar R, Pastorello E, Pitsios C, Rotiroti G, Timmermans F, Tsilochristou O, Varga EM, Wilkinson J, Williams A, Worm M, Zhang L, Sheikh A.

Clin Transl Allergy. 2016 Mar 22;6:12. doi: 10.1186/s13601-016-0099-6. eCollection 2016. Erratum in: Clin Transl Allergy. 2017 Sep 15;7:29.

18.

The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.

Worm M, Köhler EC, Panda R, Long A, Butler LM, Stavrou EX, Nickel KF, Fuchs TA, Renné T.

Ann Transl Med. 2015 Oct;3(17):247. doi: 10.3978/j.issn.2305-5839.2015.09.07. Review.

19.

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, Lockey RF, El-Gamal YM, Brown SG, Park HS, Sheikh A.

World Allergy Organ J. 2015 Oct 28;8(1):32. doi: 10.1186/s40413-015-0080-1. eCollection 2015.

20.

Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study.

Manger B, Hiepe F, Schneider M, Worm M, Wimmer P, Paulus EM, Schwarting A.

Clin Exp Gastroenterol. 2015 Jul 21;8:205-13. doi: 10.2147/CEG.S81922. eCollection 2015.

Supplemental Content

Loading ...
Support Center